Access links:
Access links:

Background. The extent to which immunologic and clinical biomarkers influence human immunodeficiency virus type 1 (HIV-1)...
Background/Aims: Orthotopic liver transplantation (OLT) is an important therapeutic option for HBV-related endstage- liver...
Background: Despite the extensive genetic diversity of HIV-1, viral evolution in response to immune selective pressures...
Background. Kaposi sarcoma–associated herpesvirus (KSHV) infection is endemic among adult populations in Africa. A prevailing...

11-13 November 2012 | Cambridge, MA, USA The key objectives of this congress are: To provide a state-of-the-art report for scientists,...
The Organising Committee of the Global Questions in Advanced Biology Conference is pleased to invite you...
The Fundación Valenciana de Estudios Avanzados organises a seminar on the treatment, the prevention and the eradication of the...

Financing entity: European Comission
Participant entities: Universite Pierre et Marie Curie, University of Regensburg, FIT Biotech Oy Ltd, CHARITE, St George’s University of London, MRC Medical Research Council, IMPACTA, Centre National de la Recherche Scientifique, INSERM, Instituto Nacional de Saúde, GENEART AG, NOVAMEN
Research Supervisor(s): Christian Brander